English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/215210
logo share SHARE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

AuthorsO'Day, E.; Hosta-Rigau, L.; Oyarzún, D.A.; Okano, H.; de Lorenzo, V.; von Kameke, C.; Alsafar, H.; Cao, C.; Chen, G.Q.; Ji, W.; Roberts, R.J.; Ronaghi, M.; Yeung, K.; Zhang, F.; Lee, S. Y.
gene editing
precision medicine
stem cells
tissue engineering.
Issue Date2019
CitationBiotechnology journal 14(1): e1800195 (2019)
AbstractPatient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-rays reveal a fractured hip, which will require total hip replacement surgery.
Publisher version (URL)http://dx.doi.org/10.1002/biot.201800195
Identifiersdoi: 10.1002/biot.201800195
issn: 1860-7314
pmid: 29799175
Appears in Collections:(CNB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.